CFB 135 (Fenofibric Acid Delayed-Release 135 mg)
Pill with imprint CFB 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Aurobindo Pharma Limited.
Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CFB 135
Fenofibric Acid Delayed-Release
- Imprint
- CFB 135
- Strength
- 135 mg
- Color
- Blue & Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 59651-0217
More about fenofibric acid
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (25)
- Drug images
- Pricing & coupons
- En español
- Drug class: fibric acid derivatives
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.